Your Trusted Premier Platform Uniting the Microbiome Therapeutics Industry for Almost a Decade
The 9th Microbiome Movement Drug Development Summit is the industry-leading forum uniting the global microbial therapeutics industry across Live Biotherapeutics, FMT, Microbiome Derived, Targeting Small Molecules and more.
This is your crucial yearly touchpoint to collaborate and network with industry pioneers, as C-Level executives and investors gather to close the translational gap, generate robust clinical data and bring efficiency to community-wide manufacturing.
Watch: Highlights and Testimonials from the Microbiome Movement Drug Development Summit 2022
Unmissable Agenda Highlights Include:
Explore
How candidates are clinically progressing with Freya Biosciences, Maat Pharma & MRM Health, with MoA discoveries to lead to synergistic and accelerated pipeline development
Uncover
Investment community perspectives on the latest innovative microbiome platform developments, to secure capital and scale your biotech business with Conundrums Systems Biology, Seventure Partners, Fast-Track Initiative & Bill & Melinda Gates Foundation
Expertly Navigate
The field’s biggest bottlenecks through a program curated to address the latest novel R&D, strategic portfolio planning, clinical, translational & manufacturing intelligence
Dive
Into interactive sessions, with workshops, roundtables, panels, poster sessions and more, to strengthen your connections with field experts to accelerate future collaboration
Discover
The adoption of AI, ML, multi-omic, metabolomic and computational techniques revealing novel microbiome biomarkers to expedite R&D into viable drug candidates with Merck, Pfizer, UC San Diego
Connect with the Microbiome Therapeutics Industry
Beyond scientific and strategic content, the 9th Microbiome Movement Drug Development Summit is designed to be the industry’s best partner for connection building in 2024.
As the leading minds of the field gather under one roof alongside trailblazing start-ups, solution providers, regulatory and investor leadership, the program is built upon the backbone of supporting networking experiences to progress microbial therapeutics with invigorated investment.
